Finally, AMER1 displayed alterations both in CCA cell lines and CCA tissue samples, while mutations in AXIN1, AXIN2, and TCF7L2 were exclusive to patients’ samples. This evidence concerns the gene AMER1 and cholangiocarcinoma.